A phase&nbsp;I study of CAR‑T bridging HSCT in patients with acute CD19<sup>+</sup> relapse/refractory B‑cell leukemiaYongyong Ma,Shenghui Zhang,Hongliang Fang,Kang Yu,Songfu JiangOncology Letters(2020)引用 11|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要